COLO 783Homo sapiens (Human)Cancer cell line

Also known as: Colorado 783, COLO783, Colo783, COLO #783, COLO-783

🤖 AI SummaryBased on 6 publications

Quick Overview

Human cancer cell line for research on tumor biology and drug sensitivity.

Detailed Summary

COLO 783 is a human cancer cell line derived from a tumor, widely used in cancer research. It is part of the Cancer Cell Line Encyclopedia (CCLE) and has been characterized for its genetic and molecular profiles. This cell line is utilized in studies related to cancer genomics, drug response, and molecular mechanisms of tumorigenesis. Its applications include investigating gene expression, mutations, and therapeutic targets, contributing to the development of personalized cancer treatments.

Research Applications

Cancer genomicsDrug response profilingMolecular mechanisms of tumorigenesisPersonalized cancer treatment development

Key Characteristics

Part of the Cancer Cell Line Encyclopedia (CCLE)Characterized for genetic and molecular profilesUsed in studies of gene expression and mutations
Generated on 6/17/2025

Basic Information

Database IDCVCL_1997
SpeciesHomo sapiens (Human)
Tissue SourceRight axillary lymph node[UBERON:UBERON_0001097]

Donor Information

Age48
Age CategoryAdult
SexFemale

Disease Information

DiseaseMelanoma
LineageSkin
SubtypeMelanoma
OncoTree CodeMEL

DepMap Information

Source TypeDSMZ
Source IDACH-000812_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Pro27Leu (c.80C>T)Homozygous-Unknown, Unknown
MutationSimpleTERTc.1-146C>T (c.250C>T) (C250T)UnspecifiedIn promoterPubMed=31068700
MutationSimpleCDKN2Ap.Pro48Leu (c.143C>T)Unspecified-PubMed=17260012
MutationSimpleCDKN1Bp.Glu14fs*109 (c.39_43delGGAGC)Heterozygous-Unknown, Unknown
MutationSimpleBRAFp.Val600Glu (c.1799T>A)Unspecified-PubMed=26214590

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11
D13S317
11,12
D16S539
9
D18S51
13,14
D19S433
13,14
D21S11
30,33.2
D2S1338
17,25
D3S1358
16
D5S818
11
D7S820
8
D8S1179
13,15
FGA
20,21
Penta D
13,15
Penta E
13
TH01
7,9.3
TPOX
9,11
vWA
18,19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.

Golub T.R., Root D.E., Hahn W.C.

Sci. Data 1:140035-140035(2014).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Immunocytochemical analysis of cell lines derived from solid tumors.

Quentmeier H., Osborn M., Reinhardt J., Zaborski M., Drexler H.G.

J. Histochem. Cytochem. 49:1369-1378(2001).